Orange County NC Website
DocuSign Envelope ID:E8C538EF-9595-4E36-A4C9-2CA66C7BE34A <br /> PBM Services as of the Effective Date. Such data includes, without limitation, prior utilization <br /> reports,pharmacy transfer files, and eligibility. <br /> 4.2 Eligibility Data: Plan Sponsor §hall provide Envision (either directly or through an <br /> authorized third party administrator) with an Eligibility File, at least monthly, in the HIPAA 834 <br /> standard transaction code set format, or such other format as has been previously agreed to by <br /> Envision. Plan Sponsor shall provide timely eligibility updates (for example, additions, <br /> terminations, change of address or personal information, etc.)to ensure accurate determination of <br /> the eligibility status of Covered Individuals. Plan Sponsor acknowledges and agrees that (i) <br /> Envision provides such eligibility data to the Participating Pharmacies and understands that <br /> Envision and Participating Pharmacies will act in reliance upon the accuracy of data received <br /> from Plan Sponsor; (ii) Envision will continue to rely on the information provided by Plan <br /> Sponsor until Envision receives notice that such information has changed; and (iii) Envision <br /> shall not be liable to Plan Sponsor for any Claims or expense resulting from the provision by <br /> Plan Sponsor (or its designee) of inaccurate, erroneous, or untimely information. In addition, if <br /> Envision must create or update eligibility by manually entering Covered Individual data, Plan <br /> Sponsor will be charged a data entry fee as specified in Exhibit 1. In lieu of the Eligibility File, <br /> Plan Sponsor may provide eligibility information by updating the Claims Adjudication System <br /> directly (except for the initial Eligibility File, which must be provided to Envision during the <br /> initial implementation), provided Plan Sponsor continues to meet Envision's conditions and <br /> specifications for direct eligibility updates. <br /> 4.3 Benefit Plan: Plan Sponsor shall provide Envision with complete information concerning <br /> the Benefit Plan. Plan Sponsor understands and agrees that Envision shall rely on the terms and <br /> provisions provided by Plan Sponsor on the Benefit Specification Form. The Benefit <br /> Specification Fotrrr may be changed from time to time by Plan Sponsor by providing Envision <br /> with a replacement Benefit Specification Form or a Benefit Specification Change Form; <br /> provided, however, that the form must be signed by Plan Sponsor to be effective and the form <br /> provided to Envision at least thirty (30) days before any such change shall be implemented. If, <br /> however, Plan Sponsor provides Envision with an unsigned Benefit Specification Form or <br /> Benefit Specification Change Form, Envision shall not be bound by such form and Plan Sponsor <br /> shall hold harmless Envision for any consequences resulting from any changes not implemented. <br /> The most recent executed Benefit Specification Form shall supersede any prior dated faun. <br /> Plan Sponsor shall have sole authority to determine the terms of the Benefit Plan and the <br /> coverage of benefits thereunder, however, Plan Sponsor understands and agrees that any change <br /> in the Benefit Plan or System configuration (e.g. mandatory generic program, coverage of over- <br /> the-counter drugs or medications, source of Covered Drugs, use of Plan Sponsor Owned <br /> pharmacies, etc.) may affect yields in Manufacturer Derived Revenue and/or average drug <br /> pricing. Plan Sponsor agrees that Envision shall not be liable to Plan Sponsor for any reduction <br /> of such yields or increase in pricing which result from any such change created by the Plan <br /> Sponsor. Further, any change to the Benefit Plan that affects a material term of this Agreement <br /> will require an amendment hereto. Plan Sponsor agrees to execute an amendment, at Envision's <br /> request,before implementing the change to the Benefit Plan. <br /> 4.4 Fotnrulary: Plan Sponsor hereby adopts and shall adhere to the Formulary identified in <br /> \Pass-through PBMSA(041917) ©Envision Pharmaceutical Services,LLC Page 10 of 41 <br />